BrightSpring Health Services Inc has a consensus price target of $20.27 based on the ratings of 14 analysts. The high is $30 issued by UBS on January 29, 2025. The low is $11.5 issued by Deutsche Bank on February 20, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, Morgan Stanley, and UBS on May 13, 2025, May 9, 2025, and January 29, 2025, respectively. With an average price target of $27.33 between Wells Fargo, Morgan Stanley, and UBS, there's an implied 15.57% upside for BrightSpring Health Services Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/13/2025 | Buy Now | 14.16% | Wells Fargo | Stephen Baxter53% | $25 → $27 | Maintains | Overweight | Get Alert |
05/09/2025 | Buy Now | 5.71% | Morgan Stanley | Erin Wright 79% | $20 → $25 | Maintains | Overweight | Get Alert |
01/29/2025 | Buy Now | 26.85% | UBS | A.J. Rice70% | $22 → $30 | Maintains | Buy | Get Alert |
12/17/2024 | Buy Now | -15.43% | Morgan Stanley | Erin Wright 79% | $19 → $20 | Maintains | Overweight | Get Alert |
12/12/2024 | Buy Now | 14.16% | CJS Securities | Larry Solow50% | → $27 | Initiates | → Market Outperform | Get Alert |
12/11/2024 | Buy Now | -11.21% | B of A Securities | Joanna Gajuk67% | $19 → $21 | Maintains | Buy | Get Alert |
11/27/2024 | Buy Now | -11.21% | Wells Fargo | Stephen Baxter53% | $17 → $21 | Maintains | Overweight | Get Alert |
11/04/2024 | Buy Now | -6.98% | UBS | A.J. Rice70% | $20 → $22 | Maintains | Buy | Get Alert |
11/04/2024 | Buy Now | -15.43% | Mizuho | Ann Hynes85% | $17 → $20 | Maintains | Outperform | Get Alert |
10/30/2024 | Buy Now | -15.43% | UBS | A.J. Rice70% | $16 → $20 | Maintains | Buy | Get Alert |
10/11/2024 | Buy Now | — | Keybanc | Matthew Gillmor66% | — | Initiates | → Sector Weight | Get Alert |
10/03/2024 | Buy Now | -15.43% | BTIG | David Larsen47% | $15 → $20 | Maintains | Buy | Get Alert |
10/01/2024 | Buy Now | -23.89% | Guggenheim | — | $15 → $18 | Maintains | Buy | Get Alert |
08/09/2024 | Buy Now | -23.89% | Goldman Sachs | Jamie Perse63% | $21 → $18 | Maintains | Buy | Get Alert |
06/21/2024 | Buy Now | -36.58% | BTIG | David Larsen47% | → $15 | Initiates | → Buy | Get Alert |
05/06/2024 | Buy Now | -32.35% | Wells Fargo | Stephen Baxter53% | $15 → $16 | Maintains | Overweight | Get Alert |
03/06/2024 | Buy Now | -45.03% | HSBC | Sidharth Sahoo53% | → $13 | Initiates | → Buy | Get Alert |
03/04/2024 | Buy Now | -2.75% | Goldman Sachs | Jamie Perse63% | $26 → $23 | Maintains | Buy | Get Alert |
02/20/2024 | Buy Now | -51.37% | Deutsche Bank | Pito Chickering68% | → $11.5 | Initiates | → Hold | Get Alert |
02/20/2024 | Buy Now | -36.58% | Leerink Partners | Whit Mayo67% | → $15 | Initiates | → Outperform | Get Alert |
02/20/2024 | Buy Now | -40.8% | B of A Securities | Joanna Gajuk67% | → $14 | Initiates | → Buy | Get Alert |
02/20/2024 | Buy Now | -36.58% | UBS | A.J. Rice70% | → $15 | Initiates | → Buy | Get Alert |
02/20/2024 | Buy Now | -36.58% | Wells Fargo | Stephen Baxter53% | → $15 | Initiates | → Overweight | Get Alert |
02/20/2024 | Buy Now | -23.89% | Jefferies | Brian Tanquilut46% | → $18 | Initiates | → Buy | Get Alert |
02/20/2024 | Buy Now | -23.89% | Morgan Stanley | Erin Wright 79% | → $18 | Initiates | → Overweight | Get Alert |
02/20/2024 | Buy Now | 9.94% | Goldman Sachs | Jamie Perse63% | → $26 | Initiates | → Buy | Get Alert |
The latest price target for BrightSpring Health (NASDAQ:BTSG) was reported by Wells Fargo on May 13, 2025. The analyst firm set a price target for $27.00 expecting BTSG to rise to within 12 months (a possible 14.16% upside). 15 analyst firms have reported ratings in the last year.
The latest analyst rating for BrightSpring Health (NASDAQ:BTSG) was provided by Wells Fargo, and BrightSpring Health maintained their overweight rating.
There is no last upgrade for BrightSpring Health
There is no last downgrade for BrightSpring Health.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BrightSpring Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BrightSpring Health was filed on May 13, 2025 so you should expect the next rating to be made available sometime around May 13, 2026.
While ratings are subjective and will change, the latest BrightSpring Health (BTSG) rating was a maintained with a price target of $25.00 to $27.00. The current price BrightSpring Health (BTSG) is trading at is $23.65, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.